diamminecyclobutane-1,1-dicarboxylatodihydroxyplatinum(IV) Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Analog of Cisplatin with reduced nephrotoxicity. Antineoplastic.

diamminecyclobutane-1,1-dicarboxylatodihydroxyplatinum(IV) Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

diamminecyclobutane-1,1-dicarboxylatodihydroxyplatinum(IV) Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

Firmenname	Telefon	E-Mail	Land	Produktkatalog	Edge Rate
Guangzhou CATO Research Chemicals Inc.	+86-020-81960175-617 +8615602392859	Intermediate@cato-chem.com	China	8322	58
QUALITY CONTROL SOLUTIONS LTD.	0755-66853366; 13670046396	ORDERS@QCSRM.COM	China	24342	58
Guangzhou Dreampharm Biotechnology Co., Ltd.	020-36607679 17825480238	3008233746@qq.com	China	9919	12
Meng Cheng Technology (Shanghai) Co., LTD	400-820-6829	sales@mitachieve.com	China	8860	58
Hubei Xinyang Medical Technology Co., Ltd	15347293736 15347293736	2853117764@qq.com	China	8932	58
Shenzhen Roark Pharma-Tec Co., Ltd.	13128912434	2880126944@qq.com	China	2577	58
Cato Research Chemicals Inc.	020-81960175-877 18933936954	tianwen.zhan@cato-chem.com	China	7735	58
HX Pharmaceutical technology co., LTD	15671363360	494267389@qq.com	China	3630	58
Shanghai Zerui Biotechnology Co., Ltd.	021-54580889 18321124657	731997554@qq.com	China	10608	58
Hubei Qingbei Yunyan Pharmaceutical Technology Co., Ltd	18162595016; 18162595016	3287908757@qq.com	China	9122	58

---

• (OC-6-33)-diammine(cyclobutane-1,1-dicarboxylato)dihydroxidoplatinum(IV)
• Carboplatin Impurity 11
• Oxocarboplatin
• 113287-15-3
• C6H14N2O6Pt